The Spectrum of Clinical, Immunological, and Molecular Findings in Familial Hemophagocytic Lymphohistiocytosis: Experience From India

Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of immune dysregulation characterized by hyperactivation of the immune system, excessive cytokine secretion and severe systemic inflammation. HLH is classified as familial (FHL) when associated with mutations in PRF1, UNC13D, STX11, and STXBP2 genes. There is limited information available about the clinical and mutational spectrum of FHL patients in Indian population. This study is a retrospective analysis of 101 molecularly characterized FHL patients over the last 10 years from 20 different referral centers in India. FHL2 and FHL3 together accounted for 84% of cases of FHL in our cohort. Patients belonging to different FHL subtypes were indistinguishable based on clinical and biochemical parameters. However, flow cytometry-based assays viz. perforin expression and degranulation assay were found to be specific and sensitive in diagnosis and classification of FHL patients. Molecular characterization of respective genes revealed 76 different disease-causing mutations including 39 (51%) novel mutations in PRF1, UNC13D, STX11, and STXBP2 genes. Overall, survival was poor (28%) irrespective of the age of onset or the type of mutation in our cohort. Altogether, this article sheds light on the current scenario of FHL in India. Our data reveal a wide genetic heterogeneity of FHL in the Indian population and confirms the poor prognosis of FHL. This study also emphasizes that though mutational analysis is important for diagnostic confirmation of FHL, flow cytometry based assays help significantly in rapid diagnosis and functional validation of novel variants identified.

[1]  S. Chiang,et al.  Current Flow Cytometric Assays for the Screening and Diagnosis of Primary HLH , 2019, Front. Immunol..

[2]  M. Madkaikar,et al.  Application of Flow Cytometry in Primary Immunodeficiencies: Experience From India , 2019, Front. Immunol..

[3]  M. Jordan,et al.  Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections. , 2019, Blood advances.

[4]  E. Haddad,et al.  How i treat primary haemophagocytic lymphohistiocytosis , 2018, British journal of haematology.

[5]  K. Mahadeo,et al.  Allogeneic hematopoietic stem cell transplantation is associated with cure and durable remission of late‐onset primary isolated central nervous system hemophagocytic lymphohistiocytosis , 2018, Pediatric transplantation.

[6]  S. Ehl,et al.  Effective Immunological Guidance of Genetic Analyses Including Exome Sequencing in Patients Evaluated for Hemophagocytic Lymphohistiocytosis , 2017, Journal of Clinical Immunology.

[7]  S. Choo,et al.  Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH. , 2017, Blood.

[8]  M. Madkaikar,et al.  Predominant Neurologic Manifestations Seen in a Patient With a Biallelic Perforin1 Mutation (PRF1; p.R225W). , 2017, Journal of pediatric hematology/oncology.

[9]  C. Blish,et al.  The newborn human NK cell repertoire is phenotypically formed but functionally reduced , 2017, Cytometry. Part B, Clinical cytometry.

[10]  M. Madkaikar,et al.  A Modified NK Cell Degranulation Assay Applicable for Routine Evaluation of NK Cell Function , 2016, Journal of immunology research.

[11]  L. Luzzatto,et al.  Genetic predisposition to hemophagocytic lymphohistiocytosis: Report on 500 patients from the Italian registry , 2016, The Journal of allergy and clinical immunology.

[12]  T. Tvedt,et al.  Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis , 2015, Genome Medicine.

[13]  S. Choo,et al.  Accuracy of flow cytometric perforin screening for detecting patients with FHL due to PRF1 mutations. , 2015, Blood.

[14]  K. Nichols,et al.  Hemophagocytic lymphohistiocytosis caused by dominant-negative mutations in STXBP2 that inhibit SNARE-mediated membrane fusion. , 2015, Blood.

[15]  K. Ghosh,et al.  Unusual Clinical Presentations of Familial Hemophagocytic Lymphohistiocytosis Type-2 , 2014, Journal of pediatric hematology/oncology.

[16]  Ammar Husami,et al.  Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. , 2014, Blood.

[17]  K. Schwarz,et al.  A new functional assay for the diagnosis of X‐linked inhibitor of apoptosis (XIAP) deficiency , 2014, Clinical and experimental immunology.

[18]  M. Weirauch,et al.  The 253‐kb inversion and deep intronic mutations in UNC13D are present in North American patients with familial hemophagocytic lymphohistiocytosis 3 , 2014, Pediatric Blood & Cancer.

[19]  V. Cetica,et al.  Familial Hemophagocytic Lymphohistiocytosis: When Rare Diseases Shed Light on Immune System Functioning , 2014, Front. Immunol..

[20]  M. Nordenskjöld,et al.  Novel deep intronic and missense UNC13D mutations in familial haemophagocytic lymphohistiocytosis type 3 , 2013, British journal of haematology.

[21]  W. Al-Herz,et al.  Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production. , 2013, Blood.

[22]  F. Gherlinzoni,et al.  Familial Hemophagocytic Lymphohistiocytosis May Present during Adulthood: Clinical and Genetic Features of a Small Series , 2012, PloS one.

[23]  S. Ehl,et al.  A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes. , 2012, Blood.

[24]  J. Meller,et al.  Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. , 2011, Blood.

[25]  K. Gilmour,et al.  Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management , 2011, Clinical and experimental immunology.

[26]  V. Cetica,et al.  Genotype–phenotype study of familial haemophagocytic lymphohistiocytosis type 3 , 2011, Journal of Medical Genetics.

[27]  A. Bizzi,et al.  Hemophagocytic lymphohistiocytosis with neurological presentation: MRI findings and a nearly miss diagnosis , 2011, Neurological Sciences.

[28]  K. Schwarz,et al.  Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases , 2010, Haematologica.

[29]  Hee-Jin Kim,et al.  UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis , 2010, Haematologica.

[30]  J. Whisstock,et al.  Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer , 2009, Proceedings of the National Academy of Sciences.

[31]  M. Aricò,et al.  Genotype–phenotype study of familial haemophagocytic lymphohistiocytosis due to perforin mutations , 2007, Journal of Medical Genetics.

[32]  H. Hennies,et al.  Mutation spectrum in children with primary hemophagocytic lymphohistiocytosis: molecular and functional analyses of PRF1, UNC13D, STX11, and RAB27A , 2006, Human mutation.

[33]  S. Ohga,et al.  Review of hemophagocytic lymphohistiocytosis (HLH) in children with focus on Japanese experiences. , 2005, Critical reviews in oncology/hematology.

[34]  H. Ariffin,et al.  Haemophagocytic lymphohistiocytosis in Malaysian children , 2005, Journal of paediatrics and child health.

[35]  A. Filipovich,et al.  Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis , 2004, Journal of Medical Genetics.

[36]  R. Clementi,et al.  Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. , 2002, Blood.

[37]  A. Fischer,et al.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis. , 1999, Science.

[38]  A. Fischer,et al.  Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. , 1996, Leukemia.

[39]  Ashley D'cruz,et al.  Experience in India , 2017 .

[40]  O. Ohara,et al.  A CD57+ CTL Degranulation Assay Effectively Identifies Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients , 2016, Journal of Clinical Immunology.

[41]  Kejian Zhang,et al.  Clinical Flow Cytometric Screening of SAP and XIAP Expression Accurately Identifies Patients with SH2D1A and XIAP/BIRC4 Mutations. , 2014, Cytometry. Part B, Clinical cytometry.

[42]  G. Janka,et al.  Familial and acquired hemophagocytic lymphohistiocytosis. , 2012, Annual review of medicine.

[43]  A. Filipovich.  Hemophagocytic lymphohistiocytosis (HLH) and related disorders. , 2009, Hematology. American Society of Hematology. Education Program.

[44]  D. Marmer,et al.  Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. , 2002, Blood.

[45]  P. Sham,et al.  Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping. , 1999, American journal of human genetics.